Isfahan COvid-19 REgistry (I-CORE): Design and methodology
Shaghayegh Haghjooy Javanmard1, Maryam Nasirian2, Behrouz Ataei3, Golnaz Vaseghi4, Atefeh Vaezi5, Tahereh Changiz6
1 Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Science, Isfahan, Iran
2 Department of Epidemiology and Biostatistics, Health School, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
5 Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6 Department of Medical Education, Medical Educational Research Center, Isfahan University of Medical Science, Isfahan, Iran
|Date of Submission||14-Mar-2020|
|Date of Decision||15-Mar-2020|
|Date of Acceptance||23-Mar-2020|
|Date of Web Publication||30-Mar-2020|
Dr. Maryam Nasirian
Isfahan University of Medical Sciences, Hezarjarib Blvd, Isfahan
Source of Support: None, Conflict of Interest: None
Health authorities usually exploit after-action reports to collect data on their experience in responding to public health emergencies. To develop an effective approach to manage and learning from health emergencies, we have launched Isfahan COvid-19 REgistry for data collection during routine clinical careas a first “critical incident registry” in Iran. Registries can be employed to explain the natural history of the disease, learn about a particular disease in terms of patient outcomes, the cost-effectiveness of clinical management, monitoring the quality of health-care service, and developing research hypotheses.
Keywords: Coronavirus, Covid-19, Isfahan, Isfahan Covid-19 registry, methodology, registry
|How to cite this article:|
Javanmard SH, Nasirian M, Ataei B, Vaseghi G, Vaezi A, Changiz T. Isfahan COvid-19 REgistry (I-CORE): Design and methodology. J Res Med Sci 2020;25:32
|How to cite this URL:|
Javanmard SH, Nasirian M, Ataei B, Vaseghi G, Vaezi A, Changiz T. Isfahan COvid-19 REgistry (I-CORE): Design and methodology. J Res Med Sci [serial online] 2020 [cited 2023 Jun 5];25:32. Available from: https://www.jmsjournal.net/text.asp?2020/25/1/32/281624
| Introduction|| |
Primary epidemiologic and clinical investigations are critical to be established early in an outbreak of a new virus. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new betacoronavirus, caused an easy spreading disease called coronavirus disease 2019 (COVID-19). The disease has spread globally since 2019 based on the World Health Organization (WHO) reports, resulting in the 2019–2020 coronavirus pandemic.
The current emergence of COVID-19 means that many aspects of the disease including transmission patterns, severity, clinical features, and risk factors remain unclear.
Studies to assess the epidemiology and clinical characteristics of cases in different settings are therefore critical to furthering our understanding of this virus and associated disease. They will also provide the robust information needed to refine the parameters to feed in forecasting models.
Registries are structured systems that use observational study methods to gather consistent demographic and clinical history and fate data to assess identified outcomes for a population defined by a particular disease, condition, or exposure and serve programmed scientific, clinical, or policy purpose (s). Studies derived from well-designed and well-performed patient registries can provide decisive data of patient exposures and outcomes. They also can assess the quality and cost-effectiveness of health services and formulate imperative evidences for policy/decision-making purposes. Registries are also working for quality improvement as a result of feedback of data.
Isfahan COvid-19 REgistry (I-CORE) enables data collection during health-care service delivery, empowering the observational studies of disease and treatment as an effective tool for many purposes such as recognizing variations in treatment and outcomes; safety screening finding factors that determine prognosis; and reporting quality of care, including the desirability of care and disproportion in the delivery of care.
To the best of our knowledge, I-CORE is thefirst comprehensive COVID-19 registry database, established in Iran. This article describes the design of I-CORE in Isfahan, as a “critical incident registry” experience.
| Materials and Methods|| |
I-CORE is a registry in which all confirmed and probable cases of COVID-19 acute respiratory disease data according to the WHO interim guidance for globalsurveillance from hospitals or syndromic surveillance system are collected. It was initiated and launched in February 2020.
All patients with laboratory confirmation of infection with the SARS-CoV-2, regardless of clinical signs and symptoms, defined as confirmed cases.
All patients without conclusive laboratory confirmation of infection with the COVID-19 virus but one of the below clinical condition were defined as probable cases:
- Patients with acute respiratory illness and with no other etiology that fully explains the clinical presentation and a history of travel to or residence in a country, area, or territory that has reported local transmission of COVID-19 disease during the 14 days prior to the onset of symptoms
- Patients with any acute respiratory illness and who has been a contact of a confirmed or probable case of COVID-19 disease during the 14 days prior to the onset of symptoms
- Patients with severe acute respiratory infection and who requires hospitalization and who has no other etiology that fully explains the clinical presentation.
Data are collected, according to the established protocol and glossary, using the WHO protocol and questionnaires.
The quality control committee, consisting of vice-chancellor of research, vice-chancellor of health, and vice-chancellor of treatment of Isfahan University of Medical Sciences, specialized physicians, hospitals infection control nurses, and health information technology staffs was developed.
Ethics approval was obtained from the Ethics Committee of Isfahan University of Medical Sciences (IR.MUI.MED.REC.1398.652).
| Results|| |
By March 11, there were 3083 registered patients with a diagnosis of confirmed and probable COVID-19 (56% men and 44% women) of whom 611 registered as confirmed cases (61% men and 39% women). The mean (standard deviation) and median of age of confirmed cases were 58.44 (17.0) and 60 years, respectively, as well as the youngest and oldest confirmed patients were 14 and 99 years, respectively. Around 5.6% of the confirmed cases died with a median age of 72-year-old, while 32.2% of whom were discharged from the hospital with the median age of 56 years. [Figure 1] presents the number of confirmed cases and death among registered patients from February 18 to March 11, 2020. The most registered confirmed cases (45%) lived in the center ofIsfahan Province, of whom 54.5% were admitted in two main Covid-19 referral hospitals.
|Figure 1: Number of daily registered confirmed case and death from February 18 to March 11, 2020|
Click here to view
| Discussion|| |
Despite technical progression in the pathogens specification, outbreaks of enigmatic illnesses continue to arise. COVID-19 outbreak with unusual epidemiologic characteristics should be tracked with further urgency, and investigators should scrutinize the probability of newly engineered pathogens.
The uncommonness of serious public health emergencies has complicated the improvement of public health emergency preparedness systems. We have developed asearchable dataset by type of events, contextual factors, geographic data, patient clinical features, and outcome to share lessons learned from COVID-19 outbreak and to enable comparisons.
Traditional surveillance and expert clinicians will always play a serious role in the perfect management of the patients and public health emergencies. However, registries are excellent tools that clearly have a role in detecting and monitoring outbreaks. The work to be done over the future months is to augment our data integration infrastructure, develop and refine our methods, and organize secondary studies based on new questions raised during patient dat gathering.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al
. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264-6.
Rau C, Palade V, Voiculescu C, Samoilescu M. The contribution of cytochemistry and electron microscopy to the detection of contaminants in the cell material used for the production of virus vaccines. Dev Biol Stand 1976;37:245-8.
|This article has been cited by|
||Sex Differences in the Relation between Comorbidities and Prognosis in Hospitalized Patients with COVID-19
| ||Noushin Mohammadifard, Fahimeh Haghighatdoost, Maryam Nasirian, Parisa Zakeri, Kamal Heidari, Shaghayegh Haghjooy Javanmard, Nizal Sarrafzadegan, Morteza Saki |
| ||Interdisciplinary Perspectives on Infectious Diseases. 2022; 2022: 1 |
|[Pubmed] | [DOI]|
||Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study
| ||Mahdi Barzegar, Amirreza Manteghinejad, Sara Bagherieh, Setayesh Sindarreh, Omid Mirmosayyeb, Shaghayegh Haghjooy Javanmard, Vahid Shaygannejad, Maryam Nasirian |
| ||BMC Neurology. 2022; 22(1) |
|[Pubmed] | [DOI]|
||COVID-19 Breakthrough Infections among Patients with Cancer Receiving Sinopharm BIBP Vaccine
| ||Amirreza Manteghinejad, Saeedeh Arabzadeh, Zahra Rezaian, Mehran Sharifi, Shaghayegh Haghjooy Javanmard |
| ||International Journal of Cancer Management. 2022; 15(10) |
|[Pubmed] | [DOI]|
||A study to design minimum data set of COVID-19 registry system
| ||Javad Zarei,Mohammad Badavi,Majid Karandish,Maryam Haddadzadeh Shoushtari,Maryam Dastoorpoor,Farid Yousefi,Hanieh Raji,Maria Cheraghi |
| ||BMC Infectious Diseases. 2021; 21(1) |
|[Pubmed] | [DOI]|
||Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus
| ||Vahid Shaygannejad,Alireza Afshari-Safavi,Boshra Hatef |
| ||Neurological Sciences. 2020; |
|[Pubmed] | [DOI]|
||Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
| ||Shaghayegh Haghjooy Javanmard,Golnaz Vaseghi,Amirreza Manteghinejad,Maryam Nasirian |
| ||Journal of Global Antimicrobial Resistance. 2020; 22: 862 |
|[Pubmed] | [DOI]|
||Toward Controlling Coronavirus Disease 2019 (COVID-19) Pandemic by Integrated Registry Systems
| ||Leila Keikha,Zeinab Mohammadzadeh,Elham Maserat |
| ||Health Scope. 2020; In Press(In Press) |
|[Pubmed] | [DOI]|